Matthias Karer Selected Research

Matthias Karer Research Topics

2	COVID-19 01/2022 - 01/2021
2	Bacteremia 01/2020 - 01/2020
2	Endocarditis 01/2020 - 12/2018
1	Acute Kidney Injury (Acute Renal Failure) 04/2022
1	Legionellosis 01/2022
1	Hemorrhage 01/2021
1	Infections 01/2021
1	Sepsis (Septicemia) 01/2020
1	Liver Diseases (Liver Disease) 12/2016
1	Cholestasis 12/2016
1	Fibrosis (Cirrhosis) 12/2016

1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2022
1	Amine Oxidase (Copper-Containing)IBA 04/2022
1	Histamine (Histamine Dihydrochloride)FDA Link 04/2022
1	Histamine N-MethyltransferaseIBA 04/2022
1	Propranolol (Inderal)FDA LinkGeneric 04/2022
1	Tacrine (Cognex)FDA Link 04/2022
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 04/2022
1	metoprineIBA 04/2022
1	FluoroquinolonesIBA 01/2022
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Cefazolin (Ancef)FDA LinkGeneric 01/2021
1	Fosfomycin FDA Link 01/2021
1	mRNA VaccinesIBA 01/2021
1	Coenzyme A (CoA)IBA 01/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	AntigensIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	CoagulaseIBA 01/2020
1	LipoglycopeptidesIBA 12/2018
1	GlycopeptidesIBA 12/2018
1	dalbavancinIBA 12/2018
1	CateninsIBA 12/2016

1	Subcutaneous Injections 01/2021
1	Personal Protective Equipment 01/2021
1	Therapeutics 12/2018